Wall Street brokerages forecast that UnitedHealth Group Inc (NYSE:UNH) will report $3.57 earnings per share for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for UnitedHealth Group’s earnings. The highest EPS estimate is $3.63 and the lowest is $3.46. UnitedHealth Group reported earnings of $3.04 per share during the same quarter last year, which would indicate a positive year over year growth rate of 17.4%. The business is expected to announce its next quarterly earnings report on Tuesday, April 16th.

On average, analysts expect that UnitedHealth Group will report full-year earnings of $14.62 per share for the current year, with EPS estimates ranging from $14.55 to $14.72. For the next financial year, analysts expect that the company will report earnings of $16.60 per share, with EPS estimates ranging from $16.38 to $16.87. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.20 by $0.08. The company had revenue of $58.42 billion for the quarter, compared to analysts’ expectations of $58.01 billion. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period last year, the business posted $2.59 earnings per share.

A number of equities research analysts have issued reports on UNH shares. Bank of America raised their target price on UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a research note on Wednesday, October 17th. Argus raised their target price on UnitedHealth Group to $285.00 and gave the company a “buy” rating in a research note on Thursday, October 18th. Cantor Fitzgerald reiterated a “buy” rating and issued a $310.00 target price on shares of UnitedHealth Group in a research note on Wednesday, November 21st. Raymond James set a $310.00 target price on UnitedHealth Group and gave the company a “buy” rating in a research note on Wednesday, November 28th. Finally, BMO Capital Markets set a $310.00 target price on UnitedHealth Group and gave the company a “buy” rating in a research note on Tuesday, November 27th. One research analyst has rated the stock with a hold rating and twenty-two have given a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and an average target price of $297.80.

UNH stock opened at $257.14 on Tuesday. The company has a current ratio of 0.73, a quick ratio of 0.69 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $251.96 billion, a price-to-earnings ratio of 19.96, a P/E/G ratio of 1.34 and a beta of 0.86. UnitedHealth Group has a 1 year low of $212.49 and a 1 year high of $287.94.

In other news, Director Richard T. Burke sold 6,090 shares of the firm’s stock in a transaction on Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total transaction of $1,715,674.80. Following the transaction, the director now directly owns 1,711,584 shares of the company’s stock, valued at $482,187,444.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction on Tuesday, January 22nd. The shares were sold at an average price of $266.61, for a total value of $1,333,050.00. Following the transaction, the director now directly owns 77,702 shares in the company, valued at $20,716,130.22. The disclosure for this sale can be found here. Insiders have sold 26,090 shares of company stock worth $6,956,975 over the last three months. Corporate insiders own 0.87% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of UNH. TIAA CREF Investment Management LLC grew its holdings in UnitedHealth Group by 7.3% during the third quarter. TIAA CREF Investment Management LLC now owns 5,462,680 shares of the healthcare conglomerate’s stock worth $1,453,291,000 after acquiring an additional 370,179 shares during the period. Financial Enhancement Group LLC grew its holdings in UnitedHealth Group by 2,579.3% during the third quarter. Financial Enhancement Group LLC now owns 1,554 shares of the healthcare conglomerate’s stock worth $413,000 after acquiring an additional 1,496 shares during the period. BLB&B Advisors LLC grew its holdings in UnitedHealth Group by 5.8% during the fourth quarter. BLB&B Advisors LLC now owns 1,198 shares of the healthcare conglomerate’s stock worth $298,000 after acquiring an additional 66 shares during the period. Sawtooth Solutions LLC grew its holdings in UnitedHealth Group by 34.4% during the third quarter. Sawtooth Solutions LLC now owns 4,413 shares of the healthcare conglomerate’s stock worth $1,174,000 after acquiring an additional 1,129 shares during the period. Finally, Bluefin Trading LLC acquired a new position in UnitedHealth Group during the third quarter worth about $578,000. 90.80% of the stock is currently owned by institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: What are defining characteristics of a correction?

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.